To earn CME related to this news article, click here. January 21, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of the potential for ...

PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. MYL, +0.23% today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, ...

Aug. 10, 2005 — The U.S. Food and Drug Administration (FDA) approved in May revisions to safety labeling to advise that prophylactic use of fondaparinux sodium injection is associated with an ...

New Delhi, Dec 27 (PTI) Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to ...

HYDERABAD, India & BRISBANE, Australia--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final ...

Mylan Inc. ( MYL) is all set to acquire the U.S. commercialization, marketing and intellectual property rights to Arixtra injection from Aspen Global Incorporated for $225 million (initial payment).

GlaxoSmithKline Receives Approvable Letter For New Indications For ARIXTRA(R)(Fondaparinux Sodium) Injection PHILADELPHIA, Feb. 2 -- GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug ...

GlaxoSmithKline has received approval in Japan for its key respiratory product Seretide/Advair Diskus and its anti-thrombotic Arixtra, a move which the company says should make a significant ...

Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today ...

PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and ...